This poster, presented at ENDO 2022, summarizes key findings from an interim analysis of an online educational program, “Incretins Update: A Holistic Approach to Patients With Type 2 Diabetes and Cardiometabolic Comorbidities,” developed by Clinical Care Options in partnership with the Endocrine Society. These findings illustrate the need for continued education for healthcare professionals on the use of incretin therapies for type 2 diabetes.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.